Filter posts

Cancer Docs Weigh in on Medicare Part B Demo

This week, American Society of Clinical Oncology (ASCO) President Daniel Hayes, MD and CEO Clifford …

2016 BIO Animal Biotech Summit Day One Highlights

BIO concluded its 2016 Animal Biotech Summit on Friday, September 23, 2016. BIO chose “One Health” …

All Pharma Wants to Be “Patient-Centric” – What Does That Really Mean?

The concept “patient-centricity” has become a pharmaceutical industry buzzword in recent years, making it difficult …

What They’re Saying about the Medicare Part B Demo

Back in March, CMS’s Center for Medicare and Medicaid Innovation (CMMI) proposed a sweeping demonstration …

How Animal Biotech Harnesses Nature's Power to Fight Disease

Forbes’ GMO Answers column looks at the tremendous potential of animal biotechnology to combat human …

Be Prepared This Flu Season and Get Vaccinated

It can only mean one thing when long summer days have come to an end, …

NORD President: Congress must act now to help 15 million sick children

Writing in The Hill, National Organization for Rare Disorders (NORD) President and CEO Peter Saltonstall …

BIO Launches New Website Holding Insurers Accountable: Un-surance.com

BIO is undertaking an aggressive effort to promote the value of biopharmaceutical innovations and ensure …

ICYMI: Potential New Drug for Alzheimer’s Shows Promise in Early Trial

Last week, the Washington Post published an article titled Alzheimer’s Drug Trial Sparks Optimism which …

ICYMI: Making Biopharmaceutical Innovation a Priority of the Next Administration

Last week, Astellas Americas President Jim Robinson wrote an op-ed in Forbes exploring, “How The …